Phase II Trial Assessing Granulocyte-macrophage—Colony Stimulating Factor, Ketoconazole Plus Mitoxantrone in Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Treatments

Castration Resistant ◽

Macrophage Colony ◽

Phase II trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer

Molecular and Clinical Oncology ◽

10.3892/mco.2015.571 ◽

2015 ◽

Vol 3 (4) ◽

pp. 865-868 ◽

Cited By ~ 5

Author(s):

LEI SONG ◽

XIJIAN ZHOU ◽

XIANGYONG LI

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Older Patients ◽

Phase Ii Trial ◽

Castration Resistant ◽

Macrophage Colony ◽

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2007.00101.x ◽

2007 ◽

Vol 3 (3) ◽

pp. 148-155

Author(s):

Ian D DAVIS ◽

Guy TONER ◽

Adam BROAD ◽

Louise M CAMPANO ◽

Mark ROSENTHAL

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Macrophage Colony ◽

Stimulating Factor ◽

P53 Peptides

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70007-4 ◽

2012 ◽

Vol 13 (5) ◽

pp. 509-517 ◽

Cited By ~ 262

Author(s):

Alfons JM van den Eertwegh ◽

Jurjen Versluis ◽

H Pieter van den Berg ◽

Saskia JAM Santegoets ◽

R Jeroen A van Moorselaar ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Prostate Cancer Cells ◽

Castration Resistant ◽

Macrophage Colony ◽

Stimulating Factor ◽

Combined Immunotherapy

Biomarkers for Clinical Outcome of Combined Immunotherapy with Granulocyte-Macrophage Colony-Stimulating Factor-Tranduced Allogeneic Prostate Cancer Cells (GVAX) and Ipilimumab in Castration-Resistant Prostate Cancer Patients (CRPC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33473-6 ◽

2012 ◽

Vol 23 ◽

pp. ix301-ix302 ◽

Cited By ~ 1

Author(s):

W.R. Gerritsen ◽

S. Santegoets ◽

A. Stam ◽

K. Hege ◽

J. Versluis ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Prostate Cancer Cells ◽

Castration Resistant ◽

Macrophage Colony ◽

Stimulating Factor ◽

Combined Immunotherapy

A phase II trial of ketoconazole plus granulocyte/macrophage-colony stimulating factor (GM-CSF) in androgen independent prostate cancer (AIPC) patients (pts)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4614 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4614-4614

Author(s):

A. M. Lin ◽

C. J. Ryan ◽

J. Rosenberg ◽

B. I. Rini ◽

T. Nguyen ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Gm Csf ◽

Macrophage Colony ◽

Stimulating Factor ◽

Androgen Independent

A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy

Avicenna Journal of Medicine ◽

10.4103/2231-0770.83718 ◽

2011 ◽

Vol 1 (1) ◽

pp. 12

Author(s):

Chadi Nabhan ◽

Andrew Meyer ◽

Kathy Tolzien ◽

JacobD Bitran ◽

TimothyM Lestingi

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Single Agent ◽

Pilot Trial ◽

Castration Resistant ◽

Macrophage Colony ◽

113 POSTER Phase II trial to assess the activity of MVA5T4 (Trovax®) alone versus MVA5T4 plus granulocyte macrophage colony-stimulating factor (GM-CSF) in patients (pts) with progressive hormone refractory prostate cancer (HRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)70119-7 ◽

2006 ◽

Vol 4 (12) ◽

pp. 38

Author(s):

R. Amato ◽

M. Karediy ◽

A. Cao ◽

M. Khan ◽

S. Naylor ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Gm Csf ◽

Hormone Refractory ◽

Macrophage Colony ◽

Phase II Trial of Recombinant Human Macrophage Colony-Stimulating Factor in Metastatic Soft Tissue Sarcoma

Journal of Immunotherapy ◽

10.1097/00002371-199410000-00007 ◽

1994 ◽

Vol 16 (3) ◽

pp. 224-228 ◽

Cited By ~ 2

Author(s):

Feroze A. Momin ◽

Mark Zalupski ◽

Lance K. Heilbrun ◽

Lawrence Flaherty ◽

Gwen Fyfe ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Human Macrophage ◽

Metastatic Soft Tissue Sarcoma ◽

Macrophage Colony ◽

Granulocyte-Macrophage-Colony Stimulating Factor in Metastatic Renal Cell Carcinoma. A Phase II Trial

The Journal of Urology ◽

10.1016/s0022-5347(01)62035-4 ◽

1999 ◽

Vol 161 (2) ◽

pp. 733-733

Author(s):

B.I. Rini ◽

W.M. Stadler ◽

R.T. Spielberger ◽

M.J. Ratain ◽

N.J. Vogelzang

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Macrophage Colony ◽

Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy—A case report on the basis of a clinical phase II trial

Leukemia Research ◽

10.1016/0145-2126(90)90162-3 ◽

1990 ◽

Vol 14 (4) ◽

pp. 347-352 ◽

Cited By ~ 5

Author(s):

Wolfgang Hiddemann ◽

Michael Zühlsdorf ◽

Bernard Wormann ◽

Michael Koenigsmann ◽

Thomas Büchner

Keyword(s):

Case Report ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Gm Csf ◽

Clinical Phase ◽

Macrophage Colony ◽